Skip to content
OpenCapital
Get started

Utah Medical Products UTMD Return on invested capital

Return on invested capital at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
4.8%+0.3pp
TFX
TeleflexTFX
1.1%-3.1pp
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
2.6%-2.1pp
IAR
Integra LifeSciencesIART
-16.4%-16.7pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
7.4%-0.2pp
PDE
Pro-Dex, Inc.PDEX
17.3%-7.5pp

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K—
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity0×—
Current ratio28.6×+6.3×

Where this comes from

Calculated from Utah Medical Products’s reported figures.

nopat/invested capital=26.5%

Based on trailing twelve months.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's return on invested capital?
Utah Medical Products (UTMD) reported return on invested capital of 26.5% in Q4 2025.
How has Utah Medical Products's return on invested capital changed year-over-year?
Utah Medical Products's return on invested capital decreased by 16.7% year-over-year, from 31.8% to 26.5%.
What is the long-term trend for Utah Medical Products's return on invested capital?
Over 5 years (2020 to 2025), Utah Medical Products's return on invested capital has grown at a 6.4% compound annual growth rate (CAGR), from 19.4% to 26.5%.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.